Quick Answer
LISATA THERAPEUTICS, INC. reported Total Assets of $17.74 million for fiscal year 2025.
LISATA THERAPEUTICS, INC. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $17.74M | -49.3% |
| 2024 | $35.00M | -36.0% |
| 2023 | $54.69M | -25.1% |
| 2022 | $73.03M | -24.7% |
| 2021 | $97.01M | +169.5% |
| 2020 | $36.00M | +32.6% |
| 2019 | $27.15M | -39.1% |
| 2018 | $44.58M | -29.7% |
| 2017 | $63.38M | +18.4% |
| 2016 | $53.51M | -6.5% |
| 2015 | $57.21M | -54.7% |
| 2014 | $126.28M | +40.6% |
| 2013 | $89.82M | +65.1% |
| 2012 | $54.41M | -65.0% |
| 2011 | $155.33M | +8.6% |
| 2010 | $143.02M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $21.76M | -43.0% | -13.5% |
| June 30, 2025 | $25.16M | -40.9% | -13.2% |
| March 31, 2025 | $28.98M | -39.9% | -17.2% |
| December 31, 2024 | $35.00M | -36.0% | -8.4% |
| September 30, 2024 | $38.20M | -34.2% | -10.3% |
| June 30, 2024 | $42.57M | -31.7% | -11.8% |
| March 31, 2024 | $48.24M | -27.3% | -11.8% |
| December 31, 2023 | $54.69M | -25.1% | -5.8% |
- LISATA THERAPEUTICS, INC. showed a decrease of -49.3% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, LISATA THERAPEUTICS, INC.’s total assets has declined by 87.6% (from $143.02 million to $17.74 million).
- The most recent figure is from LISATA THERAPEUTICS, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: